Tranostat Injection 5 x 5 ml

Composition of Tranostat Injection 5 x 5 ml

Tranostat Injection 5 x 5 ml contains Tranexamic Acid 500 mg/5 mL injection (100 mg/mL). It belongs to the Antifibrinolytic (lysine analogue) class of medicines.

Uses of Tranostat Injection 5 x 5 ml

• Treatment and prevention of bleeding due to increased fibrinolysis such as heavy menstrual bleeding (menorrhagia)
• postoperative bleeding (including dental procedures)
• trauma-related bleeding
• epistaxis
• and other hemorrhagic conditions as advised by a doctor

Key benefits

• Reduces excessive bleeding
• Stabilizes blood clots
• Useful in surgical/trauma-related bleeding control
• Helps manage heavy menstrual bleeding under medical advice

How Tranostat Injection 5 x 5 ml works

Tranexamic acid is an antifibrinolytic agent that blocks the binding of plasminogen to fibrin, thereby preventing conversion to plasmin. This stabilizes formed blood clots and reduces excessive bleeding.

How to take Tranostat Injection 5 x 5 ml

Injection for IV use (slow IV injection/IV infusion) as prescribed by the doctor; dose and duration depend on indication and kidney function. Do not self-administer; avoid rapid IV injection.

Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.

Missed dose and overdose

If you miss a dose

Take it as soon as you remember. If your next dose is almost due, skip the one you missed — never take two doses together to catch up.

If you take too much

An overdose of this medicine may be harmful — seek medical advice immediately. Do not wait for symptoms to appear — go to the nearest emergency department and take the pack or strip with you.

Side effects of Tranostat Injection 5 x 5 ml

Most side effects of Tranostat are mild and settle as the body adjusts. Reported side effects include:

• Nausea
• vomiting
• diarrhea
• abdominal pain
• headache
• dizziness
• hypotension (with rapid IV)
• visual disturbances
• injection site reactions

Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.

Safety advice for Tranostat Injection 5 x 5 ml

Warnings and precautions

Risk of thromboembolic events (DVT/PE/stroke) especially in patients with clotting disorders or history of thrombosis; contraindicated in active intravascular clotting. Use with caution in renal impairment (dose adjustment needed). Seek urgent care for chest pain, breathlessness, leg swelling, sudden weakness, or vision changes. Avoid in subarachnoid hemorrhage unless specifically advised. Ophthalmic evaluation may be needed with prolonged use; discontinue if visual symptoms occur.

Do not take Tranostat if

Not for anyone with a known allergy to this medicine or to any ingredient in the pack. Your doctor will confirm this medicine is suitable for you.

Interactions with other medicines

Combined hormonal contraceptives (increased thrombosis risk), procoagulants/anti-inhibitor coagulant complexes, factor IX complex concentrates, thrombolytics (opposing effects), other antifibrinolytics

How to store Tranostat Injection 5 x 5 ml

Store below 25°C, protect from light. Do not freeze. Keep in original pack; use only if solution is clear and container intact.

Expert advice for Tranostat Injection 5 x 5 ml

Take it at the same time each day and complete the course. Keep your follow-up appointments and any monitoring blood tests.

Manufacturer and class

Manufacturer:

OZONE PHARMACEUTICALS LTD

Therapeutic class:

Hemostatic / Antifibrinolytic

Drug class:

Antifibrinolytic (lysine analogue)